AJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, M.-J.
Right arrow Articles by Kim, K. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, M.-J.
Right arrow Articles by Kim, K. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?

Optimal Scan Window for Detection of Hypervascular Hepatocellular Carcinomas During MDCT Examination

Myeong-Jin Kim1,2,3, Jin Young Choi1,3, Joon Seok Lim3, Jin Yong Kim1,3, Joo Hee Kim3, Young Taik Oh1,3, Eun Hye Yoo1,3, Jae Joon Chung1 and Ki Whang Kim1

1 Department of Diagnostic Radiology, Severance Hospital, Yonsei University College of Medicine, Seodaemun-ku Shinchon-dong 134, Seoul, 120-752, South Korea.
2 Institute of Gastroenterology and Brain Korea 21 Project for Medical Science, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
3 Department of Diagnostic Radiology, Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.


Figure 1
View larger version (13K):

[in a new window]
 
Fig. 1 Diagram of scan protocol over time axis in each group. Bolus tracking was started 10 seconds after start of injection of contrast medium (CM). The 100-H threshold scan delay time for early scan was 10 seconds in group (GR) 1 and was increased by 2-second increments in each group. Interscan delay was fixed at 6 seconds. Number of patients (pts) and number of hepatocellular carcinomas (HCCs) are displayed in parentheses.

 

Figure 2
View larger version (12K):

[in a new window]
 
Fig. 2A Box-and-whisker plots show median (middle line of each box), quartiles (top and bottom lines of each box), and upper and lower adjacent (upper and lower whiskers for each box) values for (A) tumor, (B) liver, and (C) tumor-to-lesion attenuation difference (TLAD) in each group in first- (light gray) and second- (dark gray) phase images. Attenuation of tumor gradually increased in first-phase images in groups 1 through 5; attenuation of tumor gradually increased in second-phase images in groups 1 through 4, but decreased in groups 5 and 6.

 

Figure 3
View larger version (10K):

[in a new window]
 
Fig. 2B Box-and-whisker plots show median (middle line of each box), quartiles (top and bottom lines of each box), and upper and lower adjacent (upper and lower whiskers for each box) values for (A) tumor, (B) liver, and (C) tumor-to-lesion attenuation difference (TLAD) in each group in first- (light gray) and second- (dark gray) phase images. Attenuation value of liver gradually increased from groups 1 to 6 for both phase images.

 

Figure 4
View larger version (12K):

[in a new window]
 
Fig. 2C Box-and-whisker plots show median (middle line of each box), quartiles (top and bottom lines of each box), and upper and lower adjacent (upper and lower whiskers for each box) values for (A) tumor, (B) liver, and (C) tumor-to-lesion attenuation difference (TLAD) in each group in first- (light gray) and second- (dark gray) phase images. Mean value for TLAD1 gradually increased in groups 1 through 4 with increasing scan delay time. Mean TLAD1 of groups 4 through 6 and mean TLAD2 of groups 1 through 4 were not statistically significant.

 

Figure 5
View larger version (14K):

[in a new window]
 
Fig. 3A Bar graphs indicate number of lesions that showed (A) higher tumor-to-liver attenuation difference (TLAD), (B) visual conspicuity, and (C) interpreter preference in each phase image in each group. Gray bars denote number of lesions for which TLAD1 was greater than TLAD2, and black bars represent number of lesions for which TLAD2 was greater than TLAD1. In groups 1 to 4, larger number of lesions showed higher contrast in second arterial phase image than in first arterial phase image. In groups 5 and 6, larger number of lesions showed higher contrast in first arterial phase images.

 

Figure 6
View larger version (20K):

[in a new window]
 
Fig. 3B Bar graphs indicate number of lesions that showed (A) higher tumor-to-liver attenuation difference (TLAD), (B) visual conspicuity, and (C) interpreter preference in each phase image in each group. Bar graph indicates summation of four interpreters' subjective rating of conspicuity of each lesion. Gray bars denote total number of lesions that were subjectively rated as being more conspicuous in first-phase image in each group by four interpreters. Hatched bars denote total number of lesions that were rated as having similar conspicuity in first- and second-phase images. Black bars denote total number of lesions that were rated as being more conspicuous in second-phase image.

 

Figure 7
View larger version (15K):

[in a new window]
 
Fig. 3C Bar graphs indicate number of lesions that showed (A) higher tumor-to-liver attenuation difference (TLAD), (B) visual conspicuity, and (C) interpreter preference in each phase image in each group. Bar graph indicates total number of lesions preferred by four interpreters. Gray bars denote total number of lesions in which interpreters preferred first-phase image, and black bars represent total number of lesions in which interpreters preferred second-phase image. In groups 1 and 2, more lesions were preferred at second arterial phase. In groups 3 through 6, more lesions were preferred at first arterial phase.

 

Figure 8
View larger version (92K):

[in a new window]
 
Fig. 4A 64-year-old woman from group 2 with small hepatocellular carcinoma (HCC) at dome of liver (arrows). Small HCC lesion is barely visible in first-phase image.

 

Figure 9
View larger version (104K):

[in a new window]
 
Fig. 4B 64-year-old woman from group 2 with small hepatocellular carcinoma (HCC) at dome of liver (arrows). Second-phase image clearly depicts heterogeneously enhancing hypervascular HCC. Most lesions in groups 1 and 2 showed better contrast in second-phase image.

 

Figure 10
View larger version (143K):

[in a new window]
 
Fig. 5A 43-year-old man from group 4 with hepatocellular carcinoma (HCC) on left lobe of liver (arrows). First-phase image shows hypervascular tumor.

 

Figure 11
View larger version (135K):

[in a new window]
 
Fig. 5B 43-year-old man from group 4 with hepatocellular carcinoma (HCC) on left lobe of liver (arrows). Lesion is barely discernible in second-phase image. Patient underwent right hepatectomy previously, and fluid-filled bowel loops are seen in right hepatic fossa.

 

Figure 12
View larger version (128K):

[in a new window]
 
Fig. 6A 65-year-old man from group 6 with small hepatocellular carcinoma (HCC) on right lobe of liver. First-phase image clearly shows hypervascular tumor (arrow).

 

Figure 13
View larger version (147K):

[in a new window]
 
Fig. 6B 65-year-old man from group 6 with small hepatocellular carcinoma (HCC) on right lobe of liver. Lesion is not seen in second-phase image. In this patient, second scan is actually taken at portal venous or hepatic parenchymal phase. Note substantial enhancement of hepatic parenchyma and hepatic vein (arrowhead).

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Roentgen Ray Society.